Kraematon Investment Advisors’s Oracle ORCL Stock Holding History

Kraematon Investment Advisors’s Portfolio ORCL Stock Details ORCL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-23	Closed	-$1.88K	–	195
2022 Q4	$1.88K	Buy	+23	New	+$1.75K	﹤0.01%	241

Other funds holding ORCL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Kraematon Investment Advisors's ORCL Position: Q1 2023 in Review

Kraematon Investment Advisors sold out of Oracle (ORCL) in Q1 2023, closing a stake of 23 shares — an estimated $1.88K sold.

Kraematon Investment Advisors first reported a position in ORCL in Q4 2022 and held it in 1 quarter. The position peaked at $1.88K in Q4 2022. 2,349 funds tracked by Wall St. Rank hold ORCL as of Q1 2023.

Kraematon Investment Advisors reported no remaining Oracle position as of Q1 2023 after selling out during the quarter.
Kraematon Investment Advisors sold 23 Oracle shares in Q1 2023, an estimated $1.88K.
Kraematon Investment Advisors first reported a position in Oracle in Q4 2022 and held it in 1 quarter.
Kraematon Investment Advisors's Oracle position peaked at $1.88K in Q4 2022.
2,349 funds tracked by Wall St. Rank held Oracle as of Q1 2023.

Based on Kraematon Investment Advisors's 13F filing for Q1 2023, filed 13 Apr 2023.